Gyrus Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-101,564
Closed -$6.55M 13
2015
Q1
$6.55M Sell
101,564
-7,700
-7% -$482K 1.09% 36
2014
Q4
$6.45M Buy
109,264
+690
+0.6% +$38.9K 1.07% 37
2014
Q3
$5.56M Buy
108,574
+1,700
+2% +$84.9K 0.97% 42
2014
Q2
$5.18M Buy
106,874
+29,675
+38% +$1.46M 0.93% 43
2014
Q1
$4.43M Buy
77,199
+70,825
+1,111% +$3.77M 0.77% 49
2013
Q4
$360K Sell
6,374
-26
-0.4% -$1.32K 0.08% 89
2013
Q3
$304K Sell
6,400
-200
-3% -$8.78K 0.07% 97
2013
Q2
$311K Buy
+6,600
New +$287K 0.07% 92

Other funds holding BMY

Gyrus Investment Management's BMY Position: Q2 2015 in Review

Gyrus Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2015, closing a stake of 101,564 shares — an estimated $6.55M sold.

Gyrus Investment Management first reported a position in BMY in Q2 2013 and held it in 8 quarters. The position peaked at $6.55M in Q1 2015. 1,448 funds tracked by Wall St. Rank hold BMY as of Q2 2015.

  • Gyrus Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2015 after selling out during the quarter.
  • Gyrus Investment Management sold 101,564 Bristol-Myers Squibb shares in Q2 2015, an estimated $6.55M.
  • Gyrus Investment Management first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 8 quarters.
  • Gyrus Investment Management's Bristol-Myers Squibb position peaked at $6.55M in Q1 2015.
  • 1,448 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2015.

Based on Gyrus Investment Management's 13F filing for Q2 2015.